Pages that link to "Q33883674"
Jump to navigation
Jump to search
The following pages link to Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children (Q33883674):
Displaying 9 items.
- Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of N-Acetylcysteine (NAC) and N-Acetylcysteine Amide (NACA) in Traumatic Brain Injury: Impact on Neurofunctional Outcome and Biomarkers of Oxidative Stress and Inflammat (Q47827678) (← links)
- N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model of traumatic brain injury (Q60308381) (← links)
- Electrical stimulation for limb spasticity in children with traumatic brain injury (Q64113228) (← links)
- Cognition based bTBI mechanistic criteria; a tool for preventive and therapeutic innovations. (Q64883256) (← links)
- Exploratory Application of Neuropharmacometabolomics in Severe Childhood Traumatic Brain Injury (Q88616147) (← links)
- Oxidized phospholipid signaling in traumatic brain injury (Q89380023) (← links)
- Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision (Q90301369) (← links)
- Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? (Q92008457) (← links)
- N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain (Q92886369) (← links)